Michael Hood, MD
Orthopaedic Surgery · West Memphis, ARNPI 1124134952
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Amgen at 38.3% of the total. Reporting peaked in 2019 at $611 and has fallen 78.0% since, to $134 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in AR, where the typical reported total is $2,620.
Across 97 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$668
- Kowa Pharmaceuticals America, Inc.$174
- Ferring Pharmaceuticals Inc.$166
- Pacira Therapeutics, Inc.$130
- Biotissue Holdings Inc.$103
- Johnson & Johnson$82
- plus $421 from 13 others
What the payments were for
- Food & beverage$1,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 38 | $668 |
| Kowa Pharmaceuticals America, Inc. | 13 | $174 |
| Ferring Pharmaceuticals Inc. | 9 | $166 |
| Pacira Therapeutics, Inc. | 6 | $130 |
| Biotissue Holdings Inc. | 3 | $103 |
| Johnson & Johnson(3 entities) | 5 | $82 |
| Bioventus LLC | 3 | $66 |
| Pacira Pharmaceuticals Incorporated | 3 | $60 |
| KCI USA, Inc. | 2 | $39 |
| Convatec Inc. | 2 | $35 |
| Cumberland Pharmaceuticals, Inc. | 2 | $33 |
| Zyla Life Sciences, Inc. | 2 | $33 |
| Pfizer | 2 | $31 |
| Smith+Nephew | 1 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Merck | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $20 |
| AbbVie | 1 | $14 |
| Astellas Pharma Global Development | 1 | $14 |
How this compares
$1,744 in reported general payments places this provider in the 40th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 135 | $1,345 |
| Prednisone | 70 | $1,124 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 57 | $769 |
| Celecoxib | 33 | $524 |
| Diclofenac Sodium | 11 | $262 |
| Cyclobenzaprine Hcl | 36 | $206 |
| Meloxicam | 101 | $197 |
| Naproxen | 12 | $168 |
| Tramadol Hcl | 32 | $138 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in West Memphis
- Benjamin StronachLittle Rock$2.5M
- Charles BarnesLittle Rock$2.1M
- Kenneth MartinLittle Rock$322K
- Wesley CoxFayetteville$309K
- William HefleyNorth Little Rock$306K
- David BumpassLittle Rock$175K
- Lawrence O'MalleyLittle Rock$151K
- Jason BrandtJonesboro$104K
- Jason SmithLittle Rock$102K
- Richard McCarthyLittle Rock$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.